Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
1919
mi
from 91732
Atlanta, GA
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Emroy University
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
1840
mi
from 91732
Grand Rapids, MI
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Helen DeVos Children's Hospital
1840
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
2356
mi
from 91732
Wilmington, DE
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Nemours/Alfred I. duPont Hospital for Children
2356
mi
from 91732
Wilmington, DE
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
964
mi
from 91732
Seattle, WA
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Seattle Children's Hospital, Research, and Foundation
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
328
mi
from 91732
Stanford, CA
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Stanford University
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
2182
mi
from 91732
Stony Brook, NY
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Stony Brook Long Island Children's Hospital
2182
mi
from 91732
Stony Brook, NY
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
1357
mi
from 91732
Houston, TX
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Texas Children's Hospital
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
1777
mi
from 91732
Birmingham, AL
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
1423
mi
from 91732
Des Moines, IA
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Iowa
1423
mi
from 91732
Des Moines, IA
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
1932
mi
from 91732
Ann Arbor, MI
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Michigan
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
648
mi
from 91732
Albuquerque, NM
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of New Mexico
648
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
1171
mi
from 91732
Oklahoma City, OK
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Oklahoma Health Sciences Center
1171
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
1352
mi
from 91732
Houston, TX
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
1357
mi
from 91732
Houston, TX
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
1763
mi
from 91732
Nashville, TN
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Vanderbilt University
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
2269
mi
from 91732
Richmond, VA
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Virginia Commonwealth University
2269
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
1569
mi
from 91732
St. Louis, MO
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Washington University
1569
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
2486
mi
from 91732
New Haven, CT
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Yale University
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass
Early Renal Replacement Therapy vs. Furosemide for Neonates With Oliguria After Cardiopulmonary Bypass
Status: Enrolling
Updated:  6/30/2014
1880
mi
from 91732
Cincinnati, OH
Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass
Early Renal Replacement Therapy vs. Furosemide for Neonates With Oliguria After Cardiopulmonary Bypass
Status: Enrolling
Updated: 6/30/2014
Cincinnati Children's Hospital Medical Center
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
430
mi
from 91732
Tucson, AZ
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Advanced Arizona Clinical Research
430
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
311
mi
from 91732
Los Gatos, CA
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Richard Cherlin, MD
311
mi
from 91732
Los Gatos, CA
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
21
mi
from 91732
Orange, CA
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
The Endocrine Medical Group, Inc.
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
2317
mi
from 91732
Coral Gables, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Clinical Research of South Florida
2317
mi
from 91732
Coral Gables, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
2315
mi
from 91732
Hollywood, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
The Center for Diabetes and Endocrine Care
2315
mi
from 91732
Hollywood, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
2134
mi
from 91732
Jacksonville, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Jacksonville Center for Clinical Research
2134
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
2311
mi
from 91732
Miami, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Coral Research Clinic
2311
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
2306
mi
from 91732
Pembroke Pines, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Pines Clinical Research, Inc.
2306
mi
from 91732
Pembroke Pines, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
2181
mi
from 91732
Port Charlotte, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Volunteer Medical Research
2181
mi
from 91732
Port Charlotte, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
1726
mi
from 91732
Chicago, IL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
John H. Stroger, Jr. Hospital of Cook County
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
1299
mi
from 91732
Omaha, NE
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Creighton Diabetes Center
1299
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
1897
mi
from 91732
Dayton, OH
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
LLC DBA AccessMD Clinical Research
1897
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
1165
mi
from 91732
Oklahoma City, OK
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Harold Hamm Diabetes Center
1165
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
2121
mi
from 91732
Orangeburg, SC
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
SC Nephrology & Hypertension Ctr
2121
mi
from 91732
Orangeburg, SC
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
1225
mi
from 91732
Dallas, TX
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
University of Texas Southwestern Medical Center
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
1348
mi
from 91732
Houston, TX
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
17070 Red Oak dr Ste 103
1348
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
1350
mi
from 91732
Houston, TX
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
West Houston Clinical Research Services (WHCRS)
1350
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
1182
mi
from 91732
San Atonio, TX
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Dialysis West University Health System
1182
mi
from 91732
San Atonio, TX
Click here to add this to my saved trials
Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial
Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial
Status: Enrolling
Updated:  7/26/2014
1762
mi
from 91732
Nashville, TN
Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial
Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial
Status: Enrolling
Updated: 7/26/2014
Vanderbilt University Medical Center
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
16
mi
from 91732
Anaheim, CA
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
16
mi
from 91732
Anaheim, CA
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
mi
from 91732
DeLand, FL
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
mi
from 91732
DeLand, FL
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
2318
mi
from 91732
South Miami, FL
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
2318
mi
from 91732
South Miami, FL
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
1512
mi
from 91732
St. Paul, MN
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
1512
mi
from 91732
St. Paul, MN
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
1164
mi
from 91732
Oklahoma City, OK
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
1813
mi
from 91732
Louisville, KY
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
1813
mi
from 91732
Louisville, KY
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
1722
mi
from 91732
Milwaukee, WI
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
1722
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
1729
mi
from 91732
Chicago, IL
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
1572
mi
from 91732
St. Louis, MO
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
1572
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
2321
mi
from 91732
Miami, FL
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
2416
mi
from 91732
Livingston, NJ
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
2416
mi
from 91732
Livingston, NJ
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
13
mi
from 91732
Los Angeles, CA
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials